MYC and cancer: Two possible explanations for this selectivity are that cancer cells may be more sensitive to adenoviral transfer of wt p53, p53 22/23 or p53 14/19, or that oncogenes such as c-myc and cyclin D1 are overexpressed in malignant but not normal cells.